Shunqiang Li
- Oncology top 5%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Matthew J. EllisX. CynthiaShyam M. KavuriLi DingRon BoseDong ShenElaine R. MardisWei Shen
- Topics
- Advanced Breast Cancer Therapies (12 papers)HER2/EGFR in Cancer Research (11 papers)Cancer-related Molecular Pathways (11 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Shunqiang Li
56 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 938
- Molecular Biology 895
- Pulmonary and Respiratory Medicine 486
- Cancer Research 463
- Radiology, Nuclear Medicine and Imaging 387
Countries citing papers authored by Shunqiang Li
This map shows the geographic impact of Shunqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunqiang Li more than expected).
Fields of papers citing papers by Shunqiang Li
This network shows the impact of papers produced by Shunqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunqiang Li. The network helps show where Shunqiang Li may publish in the future.
Co-authorship network of co-authors of Shunqiang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shunqiang Li. A scholar is included among the top collaborators of Shunqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunqiang Li. Shunqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 18 | |
| 7 | 14 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 8 | |
| 11 | 56 | |
| 12 | 26 | |
| 13 | 16 | |
| 14 | 10 | |
| 15 | 30 | |
| 16 | 50 | |
| 17 | 30 | |
| 18 | 115 | |
| 19 | 41 | |
| 20 | 89 |
About Shunqiang Li
Shunqiang Li is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 61 papers that have together received 2.3k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Oncology (938 citations), Cancer Research (463 citations) and Radiology, Nuclear Medicine and Imaging (387 citations). Shunqiang Li has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Matthew J. Ellis, X. Cynthia, Shyam M. Kavuri, Li Ding, Ron Bose, Dong Shen, Elaine R. Mardis, Wei Shen, Nicholas Goel and Adam B. Aronson. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.